Clinical Trial Update: Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for moxifloxacin (Avelox) in elderly patients with community-acquired pneumonia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Avelox (moxifloxacin)

Snippet

Sponsor: Bayer | Conditions: Pneumonia | Phase 4 | Status: COMPLETED